보도자료 제목(황반변성 미국 임상 CRO 계약 체결 보도자료) GCT to provide regulatory support for Novel Wet Age-related Macular Degeneration Treatment2021-07-13 18:06작성자caregen Updated: June 8, 2021 Permanent link: https://gctrials.com/news/gct-to-provide-regulatory-support-for-novel-wet-age-related-macular-degeneration-treatment/ 목록 이전케어젠, 2021년 2분기 실적발표caregen 2021-08-11다음케어젠, 과학기술정보통신부 우수기업연구소 지정caregen 2021-06-21 Powered by MangBoard | 워드프레스 쇼핑몰 망보드